Progress realized: trends in HIV-1 viral load and CD4 cell count in a tertiary-care center from 1999 through 2011.

Autor: Howard B Gale, Manuel D Rodriguez, Heather J Hoffman, Debra A Benator, Fred M Gordin, Ann M Labriola, Virginia L Kan

Publikováno v: PLoS ONE, Vol 8, Iss 2, p e56845 (2013)

HIV-1 RNA and CD4 cell counts are important parameters for HIV care. The objective of this study was to assess the overall trends in HIV-1 viral load and CD4 cell counts within our clinic.Patients with at least one of each test performed by the Infec

Externí odkaz: https://doaj.org/article/818a00fe55324b41bbefb4aeea0d7b65

Present and Past Influences on Current Smoking Among HIV-Positive Male Veterans

Autor: Paul J. Poppen, Hannah Cohen-Blair, Ann M. Labriola, Carol A. Reisen, Fernanda T. Bianchi, Angelike P. Liappis, Maria Cecilia Zea, Debra Benator

Publikováno v: Nicotine & Tobacco Research. 13:638-645

INTRODUCTION Cigarette smoking has become an important influence of morbidity and mortality for HIV-positive individuals in the era of highly active antiretroviral therapy. Although smoking is common among military personnel and veterans, the lasting

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f336a9e103d49b86d1791b755d383260
https://doi.org/10.1093/ntr/ntr050

Relationship Between HIV Coreceptor Tropism and Disease Progression in Persons With Untreated Chronic HIV Infection

Autor: Michael Bates, Jay R. Kostman, Eoin Coakley, Matthew Bidwell Goetz, Robert E Leduc, Roberta Luskin-Hawk, Yolanda Lie, Jodi Weidler, Ann M. Labriola

Publikováno v: JAIDS Journal of Acquired Immune Deficiency Syndromes. 50:259-266

To assess the effect of HIV coreceptor tropism (CRT) on the relative risk of progression to a composite outcome of CD4 countor =350 cells per microliter, treatment initiation, or death.CRT assays were performed after study closure in baseline samples

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba1797cd68a1676eb69db27a3b3c32ec
https://doi.org/10.1097/qai.0b013e3181989a8b

Long-Term Follow-Up of Symptomatic HIV-Infected Patients Originally Randomized to Early Versus Later Zidovudine Treatment: Report of a Veterans Affairs Cooperative Study

Autor: Nancy G. Klimas, John D. Hamilton, Philip L. Day, Merrill J. Egorin, Susan B. Zolla Pazner, George L. Drusano, Gigi R. Diamond, Charles N. Oster, Clifton A. Hawkes, Ann M. Labriola, Michael S. Simberkoff, Fred M. Gordin, Nelda P. Wray, Peter Jensen, W. Lance George, Kent J. Weinhold, Christopher J. Lahart, G. Dickinson, Pamela M. Hartigan, William A. O'Brien

Publikováno v: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 11:142-150

Following a 4-year controlled trial comparing early and later zidovudine treatment, we conducted an additional 3-year follow-up. Of the original 338 patients, 275 participated. Clinical outcome measures were AIDS and death. In the early therapy group

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::86869c6f590e493a034890748084021b
https://doi.org/10.1097/00042560-199602010-00005

Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study

Autor: Wafaa El-Sadr, David A. Cooper, Nicki Smith, Gregg Larson, Patty Bollenbeck, John Worley, Chloe Orkin, Daniela Gey, Andrzej Horban, Maxime Seligmann, Greg Thompson, Ray Nelson, David Courtney-Rodgers, Valerie Beral, Adriana Sanchez, John Chuah, Karoline Jensen, Ann M. Labriola, Jens D Lundgren, Ronald J. Prineas, Marcelo H. Losso, Richard J. Price, Billy Pick, Maria C. Rodriguez-Barradas, Norman Markowitz, J Vera, Bitten Aagaard, Karen Hennessey, Gustavo Lopardo, Cate Carey, Daniel E. Nixon, Eileen Denning, Liselotte Borup, Barbara E. Murray, Richard E. Chaisson, Christopher Hill, Kamal Mansinho, Martin J. Wiselka, Shawn K. Brown, Hakima Himmich, Jo Watson, Fionna Van Hooff, Janet Darbyshire, Frank S. Rhame, Jessica Horton, Court Pederson, Jesper Grarup, John F. Modlin, Jonathan P. Anderson, Dwight E. Peavy, Claire Rappoport, Merrie Harrison, Siu Fun L. Quan, Barbara Standridge, Julie Eckstrand, Pacharee Kantipong, Fred M. Gordin, Jorge A. Tavel, Ana Martinez, Juan Carlos López, Lisa Fosdick, Ploenchan Chetchotisakd, Ian Weller, James D. Neaton, Doug Thomas, Elizabeth Finley, Simon Portsmouth, Mirta Valdez, Waldo H. Belloso, Giuseppe Tambussi, Nicholas I. Paton, Vanita Costas, Nafisah Braimah, Sergio H. Lupo, Simon Collins, Terri Schultz, Siegfried Schwarze, David Haerry, Kien Quan, Daniel Duprez, James H. Sampson, Thomas R. Fleming, Kyung Mann Kim, Eric A. Krum, Gregory M. Anstead, Matthew Bidwell Goetz, Marcelo Wolff, Deborah Wentworth, Stefano Rusconi, Søren Reilev, Abdel Babiker, Eleanor King, Francisco Antunes, Sean Emery, David Orth, Per O. Jansson, Lawrence Fox, Martin Fisher, Mary Anne Luzar, Alan R. Lifson, David Mollerup, Rick Davey, Alan Winston, Jenny Hoy, Kiat Ruxrungtham, Michael Meulbroek, Nicole Wyman, Judith Bebchuk, José M. Gatell, Alain G. DuChene, David Munroe, Roberto C. Arduino, George Perez, Mark James Kelly

Publikováno v: PLoS ONE
PLoS ONE, Vol 5, Iss 2, p e9334 (2010)
PloS one, vol 5, iss 2
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona

BACKGROUND: The Study of Aldesleukin with and without antiretroviral therapy (STALWART) evaluated whether intermittent interleukin-2 (IL-2) alone or with antiretroviral therapy (ART) around IL-2 cycles increased CD4(+) counts compared to no therapy.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e02e4546eb935338438cf232f726b50
http://ora.ox.ac.uk/objects/uuid:aef3f5ca-a828-42a6-b782-9f2e9ba8babc